Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1965 May;18(3):334–338. doi: 10.1136/jcp.18.3.334

A circulating anticoagulant inhibiting antihaemophilic globulin

P H Pinkerton 1,2, J H Dagg 1,2, Frances Taylor 1,2
PMCID: PMC472936  PMID: 14304248

Abstract

A circulating anticoagulant inhibiting antihaemophilic globulin (A.H.G.) is described in an otherwise healthy 70-year-old woman, and the therapeutic response to steroids is discussed. The nature and pathogenesis of the anticoagulant remain obscure, but its properties and behaviour do not support an autoimmune aetiology.

Full text

PDF
334

Images in this article

336Image
on p.336

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON J. R., BUCHANAN W. W., GOUDIE R. B., GRAY K. G. Diagnostic tests for thyroid antibodies: a comparison of the precipitin and latex-fixation (Hyland TAI) tests. J Clin Pathol. 1962 Sep;15:462–471. doi: 10.1136/jcp.15.5.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ARENDS T., FERGUSON J. H., LEWIS J. H. Hemorrhagic disease with circulating inhibitors of blood clotting: anti-AHF and anti-PTC in eight cases. Blood. 1956 Sep;11(9):846–855. [PubMed] [Google Scholar]
  3. BARKHAN P. Observations on a coagulation defect characterised by thrombocytopenia with a circulating anticoagulant. S Afr J Med Sci. 1952 Dec;17(3-4):87–99. [PubMed] [Google Scholar]
  4. BIGGS R., BIDWELL E. A method for the study of antihaemophilic globulin inhibitors with reference to six cases. Br J Haematol. 1959 Oct;5:379–395. doi: 10.1111/j.1365-2141.1959.tb04049.x. [DOI] [PubMed] [Google Scholar]
  5. BRECKENRIDGE R. T., RATNOFF C. D. Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for anthemophilic factor. Blood. 1962 Aug;20:137–149. [PubMed] [Google Scholar]
  6. BRUNO M. S., BRODY H. S. Hypothromboplastinemia associated with a circulating anticoagulant and hemorrhagic diathesis. Am J Med. 1954 May;16(5):756–763. doi: 10.1016/0002-9343(54)90283-1. [DOI] [PubMed] [Google Scholar]
  7. COLLINS I. S., FERRIMAN D. G. Haemophilia-like syndrome from anticoagulants affecting the production of thromboplastin. Lancet. 1952 Oct 11;2(6737):712–714. doi: 10.1016/s0140-6736(52)91323-8. [DOI] [PubMed] [Google Scholar]
  8. COLNEY C. L., RATNOFF O. D., ELLICOTT C. E., HARTMANN R. C. Studies on the initiation of blood coagulation. II. An anticoagulant inhibiting the activation of a plasma thromboplastic factor. J Clin Invest. 1950 Sep;29(9):1182–1188. doi: 10.1172/JCI102356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DENSON K. W., BOWERS E. F. The determination of ascorbic acid in white blood cells. A comparison of W.B.C. ascorbic acid and phenolic acid excretion in elderly patients. Clin Sci. 1961 Oct;21:157–162. [PubMed] [Google Scholar]
  10. ELLIS H., HANDLEY D. A., TAYLOR K. B. Surgery in a patient with an acquired circulating anticoagulant. Lancet. 1959 Jun 6;1(7084):1167–1170. doi: 10.1016/s0140-6736(59)91181-x. [DOI] [PubMed] [Google Scholar]
  11. EVANS D. M. Haemorrhagic diathesis due to a circulating anticoagulant investigated by the thromboplastin generation test. J Clin Pathol. 1955 May;8(2):168–172. doi: 10.1136/jcp.8.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. FAVRE-GILLY J., THOUVEREZ J. P., TOURNIAIRE-LAMICQ M. Les diathèse hémorragiques par anticoagulant inhibant la formation ou l'action de la thromboplastine; à propos d'un cas personnel observé au cours d'une polyarthrite chronique évolutive. Sang. 1958;29(6):517–546. [PubMed] [Google Scholar]
  13. FROMMEYER W. B., Jr, EPSTEIN R. D., TAYLOR F. H. L. Refractoriness in hemophilia to coagulation-promoting agents: whole blood and plasma derivatives. Blood. 1950 May;5(5):401–420. [PubMed] [Google Scholar]
  14. GOUDIE R. B., ANDERSON J. R., GRAY K. G. Complement-fixing antithyroid antibodies in hospital patients with asymptomatic thyroid lesions. J Pathol Bacteriol. 1959 Apr;77(2):389–400. doi: 10.1002/path.1700770208. [DOI] [PubMed] [Google Scholar]
  15. HARDISTY R. M. Acquired haemophilia-like disease; report of a case with studies on the mode of action of the circulating anticoagulant. J Clin Pathol. 1954 Feb;7(1):26–28. doi: 10.1136/jcp.7.1.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. HENDERSON W. M. Treatment with cortisone of haemorrhagic disease due to a circulating anticoagulant. Br Med J. 1959 Mar 21;1(5124):764–767. doi: 10.1136/bmj.1.5124.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. HOUGIE C. Pseudo-haemophilia: an acquired haemorrhagic diathesis due to a circulating anticoagulant. J Clin Pathol. 1953 Feb;6(1):30–33. doi: 10.1136/jcp.6.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. LEE M. L., RACCUGLIA G. Acquired inhibitor of blood coagulation. Ann Intern Med. 1962 Jun;56:946–956. doi: 10.7326/0003-4819-56-6-946. [DOI] [PubMed] [Google Scholar]
  19. Lawrence J. S., Craddock C. G., Jr Hemophilia: The Mechanism of Development and Action of an Anticoagulant Found in Two Cases. Science. 1947 Nov 14;106(2759):473–474. doi: 10.1126/science.106.2759.473. [DOI] [PubMed] [Google Scholar]
  20. MARGOLIUS A., Jr, JACKSON D. P., RATNOFF O. D. Circulating anticoagulants: a study of 40 cases and a review of the literature. Medicine (Baltimore) 1961 May;40:145–202. [PubMed] [Google Scholar]
  21. NILSSON I. M., SKANSE B., GYDELL K. Circulating anticoagulant after pregnancy and its response to ACTH. Acta Haematol. 1958 Jan;19(1):40–50. doi: 10.1159/000205412. [DOI] [PubMed] [Google Scholar]
  22. NILSSON I. M., WENCKERT A. Hyperglobulinemia as the cause of hemophilia-like disease. Blood. 1953 Dec;8(12):1067–1077. [PubMed] [Google Scholar]
  23. NUSSEY A. M., DAWSON D. W. Haemophilia-like disease due to an auto-antibody. Br Med J. 1957 Nov 9;2(5053):1077–1079. doi: 10.1136/bmj.2.5053.1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. O'BRIEN J. R. An acquired coagulation defect in a woman. J Clin Pathol. 1954 Feb;7(1):22–25. doi: 10.1136/jcp.7.1.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. SISE H. S., GAUTHIER J., DESFORGES J., BECKER R. Spontaneous circulating anticoagulant (antifactor VIII). Am J Med. 1962 Jun;32:964–975. doi: 10.1016/0002-9343(62)90043-8. [DOI] [PubMed] [Google Scholar]
  26. SPAET T. H., KINSELL B. G. A circulating anticoagulant selectively active against human antihemophilic factor (autoimmune hemophilia). Stanford Med Bull. 1954 Nov;12(4):246–256. [PubMed] [Google Scholar]
  27. VANDENBROUCKE J., VERSTRAETE M. Occurrence and mode of action of endogenous circulating anticoagulants. J Lab Clin Med. 1956 Nov;48(5):673–689. [PubMed] [Google Scholar]
  28. WALPOT L. VERWORVEN HEMOFILIE DOOR EEN CIRCULEREND ANTICOAGULANS. Ned Tijdschr Geneeskd. 1964 Jan 18;108:127–132. [PubMed] [Google Scholar]
  29. WELLER T. H., COONS A. H. Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro. Proc Soc Exp Biol Med. 1954 Aug-Sep;86(4):789–794. doi: 10.3181/00379727-86-21235. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES